As Life Expectancy Stalls, NiaHealth Adds $5.75M in Funding to Lead Canada's Proactive Health Movement
Led by Golden Ventures, the funding accelerates the rollout of NiaHealth's Platform 2.0 and cements its role as the category-defining leader in Canada's proactive health revolution.
Article content
TORONTO — NiaHealth, the fast-growing health tech startup pioneering proactive care in Canada, today announced the close of its $5.75 million seed round, led by Golden Ventures, with participation from notable investors including Kyle Braatz (CEO, Fullscript), Satish Kanwar & Arati Sharma (Good Future / ex-Shopify), Jonathan Ehrlich (Roar Ventures), Zach Coelius (Coelius Capital), The51 women-focused venture fund, Jason Smith (CEO, Klue), Kathy Butler (CIBC), and returning investors Boris Wertz (Version One Ventures), ScaleGood Fund, Garage Capital and Ivan Yuen (Co-Founder, Wattpad). This builds on a $2.5M pre-seed raise in 2024, bringing total funding to over $8.25 million to date.
Article content
Since emerging from stealth earlier this year, NiaHealth has seen over 12,000 Canadians join its waitlist, is on track to cross 300K+ biomarker tests by end of year, and has quickly grown users 30% month-over-month, driven largely by referrals. Partnerships with the University of Alberta and high-growth companies like Ada are helping expand both its scientific research and corporate employer benefits program.
Article content
The raise comes at a critical inflection point: Canadian life expectancy has been stagnant for six years, chronic illness is on the rise, and nearly 6.5 million Canadians lack access to a nurse practitioner or family doctor. At the same time, fitness wearables and health trackers are generating more data than ever, yet health outcomes aren't improving. NiaHealth bridges that gap by giving Canadians access to the tools, technology, advanced clinical-grade healthspan testing, and one on one human clinician guidance to take action before symptoms strike.
Article content
From Tester to Investor
Article content
Matt Golden, Partner at Golden Ventures and lead investor in NiaHealth, began his relationship with the company not just as a financial backer but as a member.
Article content
'I was always healthy, but NiaHealth helped me highlight unknown health risks—as a result, I worked with the NiaHealth clinician team to make lifestyle interventions that ended up reducing my risk of diabetes by more than half upon retesting. The data was powerful, but it was the human clinical guidance that made it sustainable. That's when I knew: this isn't just another health startup. It's a movement that should benefit all Canadians and Golden Ventures needs to be a part of it.'
Article content
'We're building the most advanced, accessible, and evidence-based Longevity-as-a-Service platform in Canada,' said Sameer Dhar, Co-Founder & CEO of NiaHealth. 'We plan for everything else in life, mortgages, careers, retirement, yet most of us are flying blind when it comes to our long-term health. At NiaHealth, we believe Canadians should have the tools and clinical support to take control of their health. The earlier you know, the more you can do.'
Article content
From Proactive Annual Check-Ups to Continuous, Data-Driven Care
Article content
Over 90% of NiaHealth members discover an undiagnosed issue or risk, and more importantly, start doing something about it. With Platform 2.0 launching this summer, NiaHealth becomes the most powerful integrated proactive health platform in Canada by combining an expanding set of test data to unlock advanced personalized insights:
Article content
Integration with popular wearables like Oura Ring, Garmin, Apple Watch, and Fitbit for 365-days-a-year insights to understand the relationship between behaviours and a member's unique biomarkers;
Continuous glucose monitoring (CGM) to track how food impacts your health real-time via bluetooth;
Expansion from 50 to 100+ biomarkers offered in testing to get even more precision insights;
And commitment to having the widest range of proactive tests in Canada, adding Toxic Heavy Metals, Omega's, Advanced Thyroid tests to roll out in coming weeks.
Article content
'For too long, healthcare has been about reacting to illness. And far too many Canadians are living with preventable chronic conditions, impacting not just their health, but also placing strain on our public healthcare system,' said Sameer Dhar, CEO and Co-Founder of NiaHealth. 'But the good news is, with the help of modern longevity science and the latest technology, we can take real steps toward longer, healthier lives. Canadians deserve a roadmap, not just a diagnosis. We're here to help people not just add years to life, but energy to those years.'
Article content
What's Next: Scaling Reach, Sharpening Precision
Article content
Steered by co-founders Sameer Dhar (CEO), Tanya ter Keurs (Clinical Director), Mike Goss (COO), and Saif Uddin Mahmud (CTO), the funding will fuel the continued rollout of the NiaHealth Platform 2.0, continued product R&D into predictive features, and investment in developing human-first, AI-supported clinician support tools, and continued user expansion across Canada.
Article content
'NiaHealth changed my life, plain and simple,' remarks Richard Balan, one of NiaHealth's first members. 'As a 6-foot-tall man in my 50s, I didn't realize that decades of small, unhealthy habits had left me at significant risk for heart attack, stroke, and chronic aches and pains. The wake-up call came when I saw my results in late 2023. With the support of a 1:1 clinician, I was inspired to make key lifestyle changes, and ended up losing 40 pounds in just 12 months. My retest in 2024, along with the full suite of tests NiaHealth offers, showed I had completely turned my health around. I feel energized and renewed.'
Article content
NiaHealth is Canada's first end-to-end proactive health platform, combining advanced biomarker testing, fitness wearables integration, and personalized clinical consultation to help Canadians optimize their health decades in advance. HSA-eligible and currently available in Ontario, Alberta, British Columbia, Manitoba, Saskatchewan, Nova Scotia, New Brunswick, Newfoundland and Labrador, and Prince Edward Island. Learn more at www.niahealth.co.
Article content
Article content
Article content
Article content
Article content
Contacts
Article content
Media:
Article content
Kate Carnegie
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
13 minutes ago
- Globe and Mail
Integrated Cyber Solutions Appoints Veteran Data & AI Scientist Jeremy J. Samuelson to Cyber Future Advisory Board
VANCOUVER, British Columbia – August 14, 2025 – Integrated Cyber Solutions (CSE: ICS), (OTCQB: IGCRF) (FRA: Y4G) ('ICS' or the 'Company') is pleased to announce the appointment of Jeremy J. Samuelson as Technology Advisor to its Cyber Future Advisory Board. Mr. Samuelson is a mathematician and Data and AI Scientist with 16 years of experience architecting, building, and deploying machine learning and AI solutions across multiple sectors, including healthcare, financial services, power & utilities. He has led several large-scale security and anti-fraud initiatives, including payment fraud detection at Mastercard and identity fraud detection as Principal Data & AI Scientist within Digital Identity Engineering at Equifax. Jeremy's career includes senior leadership roles in data science and analytics at Equifax, Endava North America, SimpleMachines, Mastercard, Promontory Financial Group (an IBM company), SemanticBits, Mana Health, and Honeywell. His work spans diverse sectors—building solutions for complex data environments, high-volume transactions, and mission-critical infrastructure. In addition to his industry leadership, Jeremy serves on the Data Science Advisory Council at Hofstra University and teaches data science, machine learning, and artificial intelligence at The University of Texas at Austin and at Caltech. He holds several professional certifications, including AWS Certified Cloud Practitioner, AWS Certified Machine Learning – Specialty, and Accelerated Computing with CUDA Python from NVIDIA. Jeremy's current research focuses on Bayesian Machine Learning, privacy-preserving techniques, and causal or counterfactual inference, all of which complement ICS's mission to provide predictive, privacy-conscious, and quantum-resilient cybersecurity solutions. ' Jeremy brings an exceptional combination of academic rigor, industry-tested leadership, and deep technical expertise, ' said Alan Guibord, Chairman and CEO of Integrated Cyber. ' His insight will help position ICS at the forefront of AI-driven and quantum-resilient cybersecurity for years to come. ' In connection with his appointment, the Company has granted Mr. Samuelson, through Rho Data Solutions, LLC., 300,000 stock options at $0.25, vesting over twelve months, pursuant to the Company's stock option plan. For further information, please contact: Alan Guibord Chief Executive Officer 1 Stiles Road, Salem, New Hampshire, 03079, USA Tel: +1-212-634-9534 Email: Forward-Looking Statements This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding: the Offering and its terms, including the intended use of proceeds of the Offering; the expiry of hold periods for securities distributed pursuant to the Offering; and other matters regarding the business plans of the Company. The forward-looking statements reflect management's current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements including: the Company may use the proceeds of the Offering for purposes other than those disclosed in this news release; adverse market conditions; changes in interest and currency exchange rates; and other factors beyond the control of the Company. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions, other factors beyond the control of the Company and the risk factors with respect to the Company set out in the Company's filings with the Canadian securities regulators and available under the Company's profile on SEDAR+ at The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Featured Image @ Freepik Read more investing news on to the PressReach RSS feeds:
CTV News
13 minutes ago
- CTV News
EllisDon chosen for first phase of Fancsy Family Hospital project
EllisDon has been chosen as the construction manager to complete the first phase of the Fancsy Family Hospital project. The first phase will see construction of an administration centre with an auditorium, simulation training centre, classrooms, and office space for support staff, a multi-level parking garage, and essential site infrastructure that will support future phases for the project. Windsor Regional Hospital (WRH) said work will take around three years to complete and will be the first visible step of it. It added that elements were designed to blend with the main hospital build. The ground is expected to be broken in early 2026 for the first phase. 'This announcement is another exciting and tangible step toward delivering the new state-of-the-art hospital our community has been waiting for,' said Karen Riddell, acting president, CEO, and chief nursing executive at WRH. 'By selecting EllisDon, we are partnering with a team that has a proven track record in delivering complex healthcare infrastructure. This early work will set the stage for the full build and bring us closer to a facility that will meet the needs of our patients, families, and staff for decades to come.'
CTV News
13 minutes ago
- CTV News
Canadian venture capital deals tumble as investors wait out uncertainty: expert
Canadian venture capitalists have been less active when it comes to dealmaking this year, according to one expert who says economic uncertainty has kept many investors from expanding their portfolios. 'It's uncertain, and it's no surprise that Canadian investors are experiencing it,' David Kornacki, director of data and product at the Canadian Venture Capital & Private Equity Association (CVCA), told BNN Bloomberg in an interview on Thursday. 'There's uncertainty just in overall macroeconomic trends but also, we're seeing a pullback; Canadian venture capital is a risky investment.' Kornacki said that in 2025, investors have been less willing to take on that risk, adding that there's been a noticeable drop in funding for startups in the early stages of capital raising. 'In the pre-seed, seed and Series A stages, there is a pullback, which does drop down investment counts across the board,' he said. Much like during the COVID-19 pandemic period, investors this year have been more likely to shore up their existing portfolios rather than attempting to expand them given the uncertainty that's spread to virtually all markets and sectors due to ongoing global trade conflicts, said Kornacki. 'That's what we're seeing as well, we're seeing investors make sure that their current portfolio is reducing burn, that they're remaining capital efficient and that they have capital on hand to make sure that their portfolio can ride out this next phase of uncertainty,' he said. 'So definitely we're seeing a reduced number of deals and dollars invested, specifically on the large scale. Mega deals were down; we only had about eight mega deals, what we define as $50 million-plus. We're definitely seeing investors being more cautious.' Despite the across-the-board slowdown in venture capital deals this year, life sciences is one sector that seems to be bucking the trend, Kornacki noted. 'We saw this, again, during the times of COVID-19, which made more sense given that was a health crisis, and we saw more investment into healthcare, but we're seeing that again this year,' he said. 'It seems health and life sciences is a resilient sector that doesn't ebb and flow as much as other sectors, specifically when it comes to impact on the supply chain and macroeconomic trends.' Another positive development within Canada's venture capital space is the broadening of deals across regions outside of the country's three largest provinces, Kornacki explained. 'Back when I first joined the CVCA about eight years ago, we saw investment across basically three provinces,' he said. 'Now we're seeing investment across the board, across the country in the Prairies as well and in the East Coast and the Maritimes. It's exciting to see that investment is more cross-Canada versus the Ontario, Quebec and B.C. markets.'
